News & views

Topcon’s funding will accelerate the clinically-validated AI tools towards real-world use in patient care.

A UCL Ventures spinout is opening up the World Cup experience to more people, using accessible technology.

Academic-turned-founder Dr. Martin Pule spoke about the realities and rewards taking cancer therapies to market at I-O Converse.

A new identity for the expert commercialisation partner of UCL.

A CAR T-cell therapy developed by a UCL Ventures' spinout has shown early results for people with severe, treatment-resistant lupus.

UCL research into ‘aerogel’ technology powers the first breakthrough in 30 years.

UCL has been recognised as one of Europe’s leading universities for spinouts by the Royal Academy of Engineering’s 'Spotlight on Spinouts 2026' report.

A chance to reflect on how UCL Ventures turns world‑leading research into practical solutions that remove barriers and broaden access to opportunity.

A new report shows social ventures emerging from London’s universities are driving jobs, revenue and meaningful economic growth across the capital.

A landmark UCL study shows simple hormone patches are effective for men with locally-advanced prostate cancer.

Four UCL semiconductor research projects awarded coveted places on national incubator programme, ChipStartUK.

UCL Innovation & Enterprise joined forces with NVIDIA and HP Enterprise for the four-day UCL AI Festival in central London.